This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Technology / Codexis presents RNA manufacturing advances
Tech conference presentation

Codexis presents RNA manufacturing advances

Analysis based on 7 articles · First reported Apr 29, 2026 · Last updated Apr 29, 2026

Sentiment
20
Attention
2
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The event is positive for Codexis as it showcases its advancements in RNAi therapeutics manufacturing, potentially attracting investor interest and improving its market position. The presentations and panel discussion at TIDES USA highlight the company's innovation and expertise in a growing market segment.

Biotechnology Pharmaceuticals
Event Summary

Codexis, a provider of enzymatic solutions for therapeutics manufacturing, will present new data on its ECO Synthesis Manufacturing Platform and provide an update on regulatory engagement for its enzymatic platform at TIDES USA, held May 11-14 in Boston. The company will demonstrate advances in controlling phosphorothioate stereochemistry, improved ligation efficiency, and process performance for siRNA manufacturing. Codexis will also host an expert panel discussion, 'Stereochemistry in RNAi Manufacturing: Signal or Noise?', featuring industry leaders like John Maraganore, Frederick H. Fleitz, Alison Moore, and Raman Sehgal, to discuss the growing focus on stereochemical control and its implications for therapeutic performance and product quality.

Entities Involved
per
John Maraganore
John Maraganore, founder and former CEO at Alnylam, is a panelist at the expert discussion hosted by Codexis.
Importance 20.0 Sentiment 0.0
per
Frederick H. Fleitz
Frederick H. Fleitz, SVP of CMC and Development Chemistry at Arrowhead Pharmaceuticals, is a panelist at the expert discussion hosted by Codexis.
Importance 20.0 Sentiment 0.0
stock
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is mentioned as the former employer of panelist John Maraganore.
Importance 10.0 Sentiment 0.0
per
Raman Sehgal
Raman Sehgal, entrepreneur and host of the Molecule to Market Podcast, is a panelist at the expert discussion hosted by Codexis.
Importance 10.0 Sentiment 0.0
stock
Codexis
Importance 0.0 Sentiment 0.0
per
Alison Moore
Importance 0 Sentiment 0
stock
Arrowhead Pharmaceuticals
Importance 0 Sentiment 0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.